oncology

ORGAPRED, a France-based core facility specializing in Patient-Derived Tumor Organoid (PDTO) research, has selected the CYTOQUBE high-throughput 3D…

Determining the presence of a protein in non-tumor cells within the cancer microenvironment could be one of the keys to establishing prognosis…

Breast cancer (BCA) is one of the most common cancers worldwide, with high mortality and morbidity in women.…

Recently, the Insilico team’s research entitled “An Internal Sulfur-Lone Pair Interaction Enabled the Discovery of Potential and Sub-Family…

Kazdal D, Endris V, Allgauer M, Kriegsmann M, Leichsenring J, Volckmar AL, et al. Spatial and temporal heterogeneity…

JMIR Publications today announced the release of a timely new article in its News and Perspectives section, showcasing…

A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise’s core…

Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have…

Ataraxis AI has launched Ataraxis Breast CTX, a predictive artificial intelligence (AI) test designed to estimate individualized chemotherapy…

IntroductionHow do GLP-1RAs work?The relationship between obesity and cancerWhat current research shows about GLP-1 drugs and cancer riskConflicting…

The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) has been awarded a prestigious $3 million National…

AI tools could transform how brain tumor patients access and understand critical care information, but without careful oversight,…

ORGAPRED selects CYTOQUBE® from Hamamatsu Photonics for personalized oncology research and therapeutic discovery